Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-RG0371 | Human P2RY1 Stable Cell Line-1321N1 | Inquiry |
| CSC-RG0912 | Human P2RY1 Stable Cell Line-1321N1 astrocytoma | Inquiry |
| CSC-DC011204 | Panoply™ Human P2RY1 Knockdown Stable Cell Line | Inquiry |
| CSC-SC011204 | Panoply™ Human P2RY1 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD11711Z | Human P2RY1 adenoviral particles | Inquiry |
| LV20828L | human P2RY1 (NM_002563) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHW005828 | shRNA set against Chicken P2RY1 (NM_205333) | Inquiry |
| SHH369524 | shRNA set against Human P2RY1 (NM_002563.3) | Inquiry |
| SHH369528 | shRNA set against Mouse P2RY1 (NM_008772.4) | Inquiry |
| SHH369532 | shRNA set against Rat P2RY1 (NM_012800.1) | Inquiry |
| SHR085182 | shRNA set against Rat P2ry1(NM_012800.1) | Inquiry |
| SHR085218 | shRNA set against Mouse P2ry1(NM_008772.4) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| OE-PNDC000542 | Human P2RY1 Nanodisc | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB185651 | Rabbit P2RY1 ORF clone (XM_008266363.1) | Inquiry |
| CDCR246098 | Mouse P2ry1 ORF Clone(NM_008772.4) | Inquiry |
| CDCR377660 | Rat P2ry1 ORF Clone(NM_012800.1) | Inquiry |
| CDFR010602 | Rat P2ry1 cDNA Clone(NM_012800.1) | Inquiry |
| MiUTR1M-08841 | P2RY1 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-05578 | P2RY1 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-03925 | P2RY1 miRNA 3'UTR clone | Inquiry |
| CDCB167303 | Chicken P2RY1 ORF Clone (NM_205333) | Inquiry |
| CDCH016139 | Human P2RY1 ORF clone(NM_002563.3) | Inquiry |
With increasing numbers of deaths and high prevalence worldwide, Gastric cancer has been getting growing concerns. However, the etiology of gastric cancer carcinogenesis is multifactorial, and accompanied with various genetic alterations identifications associated with gastric tumorigenesis and progression. Gastric cancers can be classified into two types according to histological differences, epidemiology, etiology, pathogenesis and biological behavior, one is diffuse type, which is characterized by its infiltrating cells and no cohesive cancer cells with vast fibrous stroma, the other one is the intestinal type, which is featured with cohesive and glandular-like cells. Nowadays chemotherapy and molecular targeted therapy are considered as the main approaches for diffuse gastric cancer treatment.
It has been known that activation of ERK signaling led to cancer by P2RY1 receptor, whose DNA methylation states and its corresponding regulatory mechanism remain unrevealed. So, DNA methylation chip was adopted for profiling of genome-wide DNA methylation level in gastric cancer tissues. And proliferation and apoptosis of the SGC7901 gastric cancer cell line were measured after treatment with MRS2365, an apoptosis of P2RY1 receptor. Highly methylation with 4 hypermethylated sites was found in the promoter region of P2RY1 of the diffuse gastric cancer, and it was further validated by bioinformatic analysis in TCGA database. Annexin-V/PI staining and caspase-3 activity assays were chosen for indication of the MRS2365 induced apoptosis in SGC7901 cells. Reduced expression of P2RY1's mRNA induced by high DNA methylation in the promoter region of P2RY1 is echoed with 'aggressivity' of the diffuse type gastric cancer.
A paper in cell reported purinergic P2RY1 receptors in vagal sensory neurons and their involvement in series airway defense reflexes of guarding airways from external stimulus. In addition to this, P2RY1 neurons were demonstrated as one of the rarely distributed laryngeal sensory neurons, and capable of protecting our airways from blockings of ingested food and drinks. Purinergic P2RY1 receptors in vagal sensory neurons function as a sensory neuron for airway threats detection and coordinators for defensive reflexes to guard airway integrity. Experimental methods included genetically modified mouse lines and single-cell RNA sequencing were chosen for the investigation of targeting strategy or sensory molecular diversity of specific sensory neurons. And more advanced techniques, such as optogenetics, chemogenetics, calcium imaging were deployed to understand the diversity of vagal P2RY1 sensory neurons and their central mechanism of guarding respiratory tract from external assaults.
Figure 1. The illustration of MRS2365 affecting RAS-RAF-MEK-ERK signaling pathway by P2RY1 receptor (Hua et al., 2021).
References: